Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Roy Buchanan's Stock Ratings
JMP Securities Analyst
Roy Buchanan is an analyst at JMP Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/01/2025
Overall Average Return
-24.1%
Smart Score
Overall Average Return Percentile
10th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/29/2025 | CDTX | Buy Now | Cidara Therapeutics | $20.40 | 125.49% | Roy Buchanan37% | $46 → $46 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/26/2025 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | 376.19% | Roy Buchanan37% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/14/2025 | INO | Buy Now | Inovio Pharmaceuticals | $1.83 | 883.61% | Roy Buchanan37% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/12/2025 | CDTX | Buy Now | Cidara Therapeutics | $20.40 | 125.49% | Roy Buchanan37% | → $46 | Initiates | → Market Outperform | Get Alert |
| 02/25/2025 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | 376.19% | Roy Buchanan37% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/14/2025 | CVAC | Buy Now | CureVac | $3.59 | 345.11% | Roy Buchanan37% | $16 → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/13/2025 | TPG | Buy Now | TPG | $46.67 | — | Roy Buchanan37% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/11/2025 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 306.09% | Roy Buchanan37% | $7 → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/11/2025 | ENTA | Buy Now | Enanta Pharma | $6.05 | 247.11% | Roy Buchanan37% | $21 → $21 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/03/2025 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | 376.19% | Roy Buchanan37% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/30/2025 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.95 | 1373.68% | Roy Buchanan37% | $23 → $14 | Maintains | Market Outperform | Get Alert |
| 01/23/2025 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 610.66% | Roy Buchanan37% | $7 → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/10/2025 | INO | Buy Now | Inovio Pharmaceuticals | $1.83 | 883.61% | Roy Buchanan37% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/10/2025 | ABVX | Buy Now | Abivax | $7.40 | 345.95% | Roy Buchanan37% | $33 → $33 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/26/2024 | ENTA | Buy Now | Enanta Pharma | $6.05 | 247.11% | Roy Buchanan37% | $22 → $21 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/21/2024 | HOOK | Buy Now | HOOKIPA Pharma | $1.44 | 386.11% | Roy Buchanan37% | $24 → $7 | Maintains | Market Outperform | Get Alert |
| 11/19/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | 376.19% | Roy Buchanan37% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/09/2024 | ENTA | Buy Now | Enanta Pharma | $6.05 | 263.64% | Roy Buchanan37% | $22 → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/01/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan37% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 09/27/2024 | ENTA | Buy Now | Enanta Pharma | $6.05 | 263.64% | Roy Buchanan37% | $22 → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/16/2024 | CVAC | Buy Now | CureVac | $3.59 | 345.11% | Roy Buchanan37% | $16 → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/16/2024 | CVAC | Buy Now | CureVac | $3.59 | 345.11% | Roy Buchanan37% | $18 → $16 | Maintains | Market Outperform | Get Alert |
| 08/09/2024 | HOOK | Buy Now | HOOKIPA Pharma | $1.44 | 1566.67% | Roy Buchanan37% | $23 → $24 | Maintains | Market Outperform | Get Alert |
| 08/09/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | 185.71% | Roy Buchanan37% | $6 → $3 | Maintains | Market Outperform | Get Alert |
| 08/05/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan37% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2024 | ABUS | Buy Now | Arbutus Biopharma | $3.55 | 40.85% | Roy Buchanan37% | $4 → $5 | Maintains | Market Outperform | Get Alert |
| 07/03/2024 | CVAC | Buy Now | CureVac | $3.59 | 400.75% | Roy Buchanan37% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/14/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan37% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/07/2024 | ENTA | Buy Now | Enanta Pharma | $6.05 | 263.64% | Roy Buchanan37% | $23 → $22 | Maintains | Market Outperform | Get Alert |
| 04/04/2024 | ABUS | Buy Now | Arbutus Biopharma | $3.55 | 12.68% | Roy Buchanan37% | $4 → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/02/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan37% | $4 → $5 | Maintains | Market Outperform | Get Alert |
| 04/02/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | 471.43% | Roy Buchanan37% | → $6 | Upgrade | Market Perform → Market Outperform | Get Alert |
| 02/28/2024 | GRTS | Buy Now | Gritstone Bio | — | — | Roy Buchanan37% | → $4 | Initiates | → Market Outperform | Get Alert |
| 02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | — | Roy Buchanan37% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 01/04/2024 | INO | Buy Now | Inovio Pharmaceuticals | $1.83 | -45.36% | Roy Buchanan37% | → $12 | Initiates | → Market Outperform | Get Alert |
| 01/04/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | 2757.14% | Roy Buchanan37% | → $30 | Initiates | → Market Outperform | Get Alert |
| 11/21/2023 | ENTA | Buy Now | Enanta Pharma | $6.05 | 280.17% | Roy Buchanan37% | $42 → $23 | Maintains | Outperform | Get Alert |
| 11/03/2023 | DVAX | Buy Now | Dynavax Technologies | $11.48 | 135.19% | Roy Buchanan37% | $25 → $27 | Maintains | Market Outperform | Get Alert |
| 08/08/2023 | ENTA | Buy Now | Enanta Pharma | $6.05 | 594.21% | Roy Buchanan37% | $65 → $42 | Maintains | Market Outperform | Get Alert |
| 08/04/2023 | DVAX | Buy Now | Dynavax Technologies | $11.48 | 117.77% | Roy Buchanan37% | $24 → $25 | Maintains | Outperform | Get Alert |
| 07/18/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | Roy Buchanan37% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 07/06/2023 | ABUS | Buy Now | Arbutus Biopharma | $3.55 | 69.01% | Roy Buchanan37% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/09/2023 | ENTA | Buy Now | Enanta Pharma | $6.05 | 974.38% | Roy Buchanan37% | $82 → $65 | Maintains | Outperform | Get Alert |
| 05/03/2023 | DVAX | Buy Now | Dynavax Technologies | $11.48 | 109.06% | Roy Buchanan37% | $25 → $24 | Maintains | Outperform | Get Alert |
| 04/26/2023 | CVAC | Buy Now | CureVac | $3.59 | 567.67% | Roy Buchanan37% | $34 → $24 | Maintains | Outperform | Get Alert |
| 03/29/2023 | ABUS | Buy Now | Arbutus Biopharma | $3.55 | 69.01% | Roy Buchanan37% | → $6 | Reiterates | → Market Outperform | Get Alert |
| 03/15/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | Roy Buchanan37% | $9 → $5 | Maintains | Market Outperform | Get Alert |
| 03/06/2023 | ESPR | Buy Now | Esperion Therapeutics | $0.98 | 1422.84% | Roy Buchanan37% | → $15 | Reiterates | → Market Outperform | Get Alert |
| 03/03/2023 | ARGX | Buy Now | argenx | $639.90 | -29.99% | Roy Buchanan37% | $443 → $448 | Maintains | Market Outperform | Get Alert |
| 03/01/2023 | CRMD | Buy Now | Cormedix | $9.50 | 68.4% | Roy Buchanan37% | $14 → $16 | Maintains | Market Perform | Get Alert |
| 02/24/2023 | DVAX | Buy Now | Dynavax Technologies | $11.48 | 117.77% | Roy Buchanan37% | $22 → $25 | Maintains | Market Outperform | Get Alert |
| 02/16/2023 | IBIO | Buy Now | iBio | $1.03 | — | Roy Buchanan37% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 12/13/2022 | PRDS | Buy Now | Pardes Biosciences | — | — | Roy Buchanan37% | → $9 | Initiates | → Market Outperform | Get Alert |
| 11/17/2022 | CVAC | Buy Now | CureVac | $3.59 | 845.86% | Roy Buchanan37% | $37 → $34 | Maintains | Market Outperform | Get Alert |
| 09/27/2022 | DVAX | Buy Now | Dynavax Technologies | $11.48 | 91.64% | Roy Buchanan37% | → $22 | Initiates | → Market Outperform | Get Alert |
| 08/09/2022 | ENTA | Buy Now | Enanta Pharma | $6.05 | 2164.46% | Roy Buchanan37% | $103 → $137 | Maintains | Market Outperform | Get Alert |
| 06/28/2022 | ABUS | Buy Now | Arbutus Biopharma | $3.55 | 153.52% | Roy Buchanan37% | $10 → $9 | Maintains | Market Outperform | Get Alert |
| 05/19/2022 | ENTA | Buy Now | Enanta Pharma | $6.05 | 1602.48% | Roy Buchanan37% | $114 → $103 | Maintains | Market Outperform | Get Alert |
| 05/10/2022 | ENTA | Buy Now | Enanta Pharma | $6.05 | 1784.3% | Roy Buchanan37% | $116 → $114 | Maintains | Market Outperform | Get Alert |
| 04/22/2022 | CVAC | Buy Now | CureVac | $3.59 | 929.32% | Roy Buchanan37% | $52 → $37 | Maintains | Market Outperform | Get Alert |
| 01/18/2022 | CVAC | Buy Now | CureVac | $3.59 | 1346.61% | Roy Buchanan37% | → $52 | Initiates | → Market Outperform | Get Alert |
| 12/21/2021 | ARGX | Buy Now | argenx | $639.90 | -34.68% | Roy Buchanan37% | $368 → $418 | Maintains | Market Outperform | Get Alert |
| 11/29/2021 | IBIO | Buy Now | iBio | $1.03 | 45.63% | Roy Buchanan37% | → $750 | Initiates | → Outperform | Get Alert |
| 09/14/2021 | PYPD | Buy Now | PolyPid | $3.15 | 344.44% | Roy Buchanan37% | → $420 | Initiates | → Market Outperform | Get Alert |
| 08/06/2021 | ENTA | Buy Now | Enanta Pharma | $6.05 | 1172.73% | Roy Buchanan37% | $70 → $77 | Maintains | Market Outperform | Get Alert |
